News
A new study has found that linoleic acid, a common fat found in seed oils like soybean and safflower oil, can increase the ...
Investing.com -- Artelo Biosciences Inc (NASDAQ: ARTL) stock surged 10% following the presentation of positive preclinical data for its lead fatty acid binding protein 5 (FABP5) inhibitor, ART26.12, ...
14d
InvestorsHub on MSNArtelo Biosciences Shares Climb on Promising Preclinical Osteoarthritis Pain DataArtelo Biosciences Inc (NASDAQ:ARTL) saw its stock jump 10% after unveiling encouraging preclinical results for its lead drug ...
In these OA studies with ART26.12, the FABP5 inhibitor demonstrated efficacy comparable to naproxen, a commonly prescribed nonsteroidal anti-inflammatory drug (NSAID), with ART26.12 maintaining ...
A new preclinical study from Weill Cornell Medicine reveals that linoleic acid, a type of omega-6 fatty acid commonly found ...
Artelo Biosciences announces positive Phase 1 results for ART26.12, a novel FABP5 inhibitor for pain management.
Inhibiting FABP5 represents a unique mechanism of action with ART26.12 standing out as a first-in-class candidate in the field of pain management. The Phase 1 Single Ascending Dose (SAD) study was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results